LIU Yun, HU Meng-ya, ZHANG Wen-jing, FAN Yu-xin, XU Rui-wen, ZHU Deng-hui, SUN Yan-jun, FENG Wei-sheng, CHEN Hui. A new pyrazine from Hypecoum erectum L.J. Acta Pharmaceutica Sinica, 2024, 59(1): 183-187. DOI: 10.16438/j.0513-4870.2023-0475
Citation: LIU Yun, HU Meng-ya, ZHANG Wen-jing, FAN Yu-xin, XU Rui-wen, ZHU Deng-hui, SUN Yan-jun, FENG Wei-sheng, CHEN Hui. A new pyrazine from Hypecoum erectum L.J. Acta Pharmaceutica Sinica, 2024, 59(1): 183-187. DOI: 10.16438/j.0513-4870.2023-0475

A new pyrazine from Hypecoum erectum L.

  • Four pyrazines were isolated from the n-butanol fraction of Hypecoum erectum L. by using various chromatographic methods, including MCI gel, ODS, silica gel and semi-preparative HPLC. The structures of the isolated compounds were identified as hyperectpyrazin A (1), 1′S-(6-methylpyrazin-2-yl)-ethane-1′, 2′-diol (2), 2-hydroxymethyl-6-methylpyrazin (3) and pyrazine-2-carboxylic acid (4) by spectroscopy methods (1D NMR, 2D NMR, UV, IR, MS, etc.). The absolute configuration of compound 2 was determined by using the Mo2(OAc)4 induced CD analysis for the first time. Compound 1 was a new compound, compounds 2-4 were isolated from H. erectum for the first time. Compounds 1-4 were evaluated for their inhibition against acetylcholinesterase and nitric oxide generation induced by lipopolysaccharide-RAW264.7 macrophage cells. At a concentration of 50 μmol·L-1, compounds 2 and 4 displayed inhibitory effects on acetylcholinesterase with the inhibition rates of 44.40% and 43.99%, respectively.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return